BRC Therapeutics hires Jazz Pharmaceuticals veteran, but can its cannabinoid pipeline deliver?
BRC Therapeutics appoints Kimberly Spancake to strengthen cannabinoid trials targeting chronic pain and neurological disorders. See what's next.
Pharma & Biotech
Pharma & Biotech
Kairos Pharma highlights 17.7-month progression-free survival with ENV-105 combination in metastatic prostate cancer
Kairos Pharma has presented interim Phase 2 findings showing substantially longer progression-free survival with ENV-105 plus apalutamide than with apalutamide alone. However, the number of patients in the analysis and key statistical details remain undisclosed, while a redesigned trial will test the treatment earlier in the course of resistance.
Pharma & Biotech
First DOC1021 patients treated in Phase 1/2 refractory melanoma trial
DOC1021 enters a Phase 1/2 refractory melanoma trial testing personalised dendritic cell therapy without lymphodepletion or high-dose IL-2
Medical Devices & Diagnostics
Why New York approval could accelerate Quest Diagnostics’ Haystack MRD cancer strategy
Quest Diagnostics has taken Haystack MRD nationwide after New York approval. See how ctDNA testing could reshape cancer recurrence monitoring.